FDA Investigator Libia M Lugo

Libia M Lugo has conducted inspections on 115 sites in 17 countries as of 14 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
115
Last Inspection Date:
14 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Jordan, United States of America, Puerto Rico, Israel, Canada, India, Italy, Germany, Japan, Switzerland, Taiwan, United Kingdom of Great Britain and Northern Ireland, Czechia, Ireland, Bulgaria, Spain, Belgium
FDA Investigators that have inspected at least one site in common with Libia M Lugo:
Abigail A Auster, Adalberto Cajigas, Adaliz Santaliz Cruz, Adam R Cooke, Ademola O Daramola, Agnes M Santori, Alan A Rivera, Alice S Tsao, Alicia M Mozzachio, An T Vu, Ana Delp Cintron, Ana M Rivera, Ana P Barido, Anastasia G Lolas, Anastasia M Shields, Andrea George, PhD, Andria L Kuhlman, Angela E Glenn, Angelica M Hernandez, Anita Narula, PhD, Ann L Demarco, Annette Melendez, Anthony C Warchut, Ariel Cruz Figueroa, Arlene M Badillo, Arwa S El Hagrasy, Ashley N Queen, PhD, Ashutosh Rao, PhD, Azza Talaat, Barbara I Rogolsky, Barbara M Frazier, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brenda Rivera, Brenda S Zimmer, PhD, Brenda W Uratani, PhD, Brian D Nicholson, Brian J Ryan, Brittny C Cargo, Brooke K Higgins, Burnell M Henry, Calvin B Koerner, Camerson E Moore, Carla J Lundi, Carlos A Medina, Carol A Gripp, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charisse K Green, Charles R Cote, RIC, Chauncey A Stephens, Cheryl A Clausen, Chiaochun J Wang, Christina Capacci Daniel, PhD, Christopher Downey, PhD, Christopher J Adams, Christopher S Keating, Claire M Minden, Clifton C Francis, Clinton J Lott, Colleen Thomas, PhD, Connie R Kiessling, Constantin Y Philopoulos, Craig A Garmendia, Cynthia Jim, CSO, Dale A Nyberg, Dandan Wang, PhD, Daniel L Obrzut, Daphne Santiago, PhD, Darryl T Newell, David R Heiar, Dawn C Olenjack, Dawn M Mccabe, Dayna I Martinez, Delaram Moshkelani, Demario L Walls, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Devaughn Edwards, Dewayne E Whitlock, Dianiris C Ayala, Dipesh K Shah, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Christner, Dorothy P Kramer, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Dyvette Arline, Edmund F Mrak, Jr, Edward Deberry, Edward H Maticka, Edwin Martinez, Edwin Melendez, Eileen A Liu, Eileen J Bannerman, Eliezar Ramos, Emest F Bizjak, Erika E Englund, PhD, Erika V Butler, Eva I Merced Medina, Fabian Nchaparro Rodriguez, Frances L Dejesus, Frances Namuswe, PhD, Frank Flores, Frederick L Fricke, Gabriel R Mclemore, Gamal A Norton, Garcial, George J Flynn, Gerald B Seaborn, Jr, Geraldine D Sanders, German Rivera, Guerlain Ulysse, Guo Q Shen, Hai Lient Phung, Hala L Selby, Hector Jcolon Torres, Herbert M Corbello, Heriberto Negron Rivera, Inga M Warr, Iraida Ortiz, Ivis L Negron, Ivy E Sweeney, Jaime E Pares, James C Maclaughlin, Janete F Guardia, Jared P Stevens, Jason D Abel, Jason F Chancey, Javier O Vega, Jawaid Hamid, Jeffrey A Sommers, Jennifer A Quinones, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jennifer M Gogley, Jennifer M Menendez, Jerri Baker, Jessica L Pressley, Jessica P Mcalister, Jie He, Joan M Cantellops Figueroa, Joann Walters Salvatierra, Joanne E King, Jocelyn E Massey, Joey V Quitania, Jogy George, John A Gonzalez, Jonee J Mearns, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Joshua P Wireman, Juan Rjimenez Garcia, Juhong Liu, PhD, June P Page, Justin A Boyd, Justine Tomasso, Karen A Wolnik, Karl D Hezel, Katherine D Adams, Katherine Szestypalow, Katherine V Serrano, Kathleen D Culver, Kathy Lee, Kayla V Sprague, Kenneth M Gordon, Kevin A Gonzalez, Kham Phommachanh, Krishna Ghosh, PhD, Kristin M Abaonza, Kshitij A Patkar, Laiza V Garcia, Lakecha N Lewis, Lareese K Thomas, Larry K Austin, Larry K Hampton, Laura E Garcia, Lauren N Howard, Lauren N Smith, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Michael H Tollon, Leonard H Lavi, Lesley K Satterwhite, Liatte Kreuger, PharmD, Lillie D Witcher, Liming Zhang, Linda R Kuchenthal, Lisa Hayka, Lisa M Lopez, Lizaida Perez, Logan T Williams, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Carrion, Luis A Dasta, Luis Mburgos Medero, Luz N Riveradecruz, Madushini Dharmasena, PhD, Margaret M Annes, Margarita Santiago, Maria A Ruttell, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maria V Price, Marian E Ramirez, Marianela Aponte Cruz, Maridalia Torres Irizarry, Marie F Morin, Marilyn Santiago, Marisol Faberlle, Mark W Rivero, Marvin D Jones, Mary E Farbman, PhD, Mary E Storch, Marybeth Willis, Matthew B Casale, Maxwell Van Tassell, PhD, Medina, Melanie M Walker, Melissa J Garcia, Meredith P Soehl, Investigator, Michael A Charles, Michael A Taylor, Michael L Casner, Michael L Chasey, Michael R Klapal, Michael Shanks, MS, Michael Y Philopoulos, Michele L Glendenning, Michele L Obert, Michelle D Haamid, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Miguel Hernandez Sanchez, Milva E Melendez Perales, Min Tang, Minerva Rogers, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy Rosado, Nebil A Oumer, Nicholas L Hunt, Nicholas Obiri, PhD, Nicole A Lloyd, Nikolay Spiridonov, Noreen Muñiz, Norman Wong, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia A Mcilroy, Patricia D Stahnke, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul L Bellamy, Paul L Figarole, Jr, Paul Z Balcer, Paula A Trost, Penny H Mccarver, Peter C Chow, Philip F Istafanos, DMV, MS, Pratik S Upadhyay, DDC, R Edwadebey Deberry, Rachael L Cook, Rafael E Arroyo, Rafael E Cruz, Rafael Nevarez Nieves, Rakhi B Shah, Ramesh Potla, PhD, Ramon A Hernandez, Randy L Clarida, Randy L Self, Rapti D Madurawe, Raquel Gonzalez Rivera, Ravichandran Veerasamy, PhD, Raymond A Lyn, Jr, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard L Bartlett, Riley C Myers, PhD, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert Darius, Robert J Martin, Robert Rodriguez, Robert Sharpnack, Rochelle K Kimmel, Rosa J Motta, Rose Xu, Roy R Rinc, S Lori Brown, PhD MPH, Sam H Haidar, PhD, Samantha J Bradley, Samina S Khan, Sandra A Boyd, Sandra A Hughes, Santos E Camara, Sarah E Mcmullen, Saundrea A Munroe, Scott B Laufenberg, Scott T Ballard, Sena G Dissmeyer, Seneca D Toms, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shelly A Rios Laluz, Shirley J Berryman, Simone E Pitts, Sonia M Monges, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Stephanie D Crockett, Stephen D Brown, Steven A Brettler, Steven A Gonzales, Steven B Barber, Steven C Madzo, Steven D Dittert, Steven E Bowen, PhD, Steven Fong, MS, PhD, Steven M Weinman, Susan F Laska, MS, Susan M Corrales, Susan M Turcovski, Susan O Oladeji, Susan P Bruederle, Susan T Hadman, Susanna E Ford, Tajah L Blackburn, Tara G Bizjak, Theresa Kirkham (NMI), Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Timothy Wadkin, PhD, Torrance J Slayton, Toyin B Oladimeji, Travis S Bradley, Vaishali J Patel, Veronica Fuentes, MS, Victor S Pacheco, Vilmary Negron Rodriguez, Vincent M Williams, Viviana Matta, Wanda J Torres, Wendy G Tan, PhD, William Hallett, PhD, Xiaokuang Lai, PhD, Yasamin Ameri, Yeissa Chabrier Rosello, Yifan Wang, Ying Xin Fan, PhD, Ying Zhang, Youmin Wang, Yumi J Hiramine, Zachary L Miller, Zachary L Stamm, Zada L Giles, Zhong Li, PhD, Zhongren Wu

Libia M Lugo's Documents

Publish Date Document Type Title
June, 2015 FDA 483 Neolpharma, Inc. - Form 483, 2015-06-18
February, 2024 FDA 483 Baxter Healthcare Corporation - Form 483, 2024-02-09
March, 2017 FDA 483 Glenmark Pharmaceuticals Limited - Form 483, 2017-03-31
June, 2012 FDA 483 Auro PR Inc. - Form 483, 2012-06-07
June, 2017 FDA 483 Neolpharma, Inc. - Form 483, 2017-06-07
June, 2019 FDA 483 Absolutely Natural - Form 483, 2019-06-14
February, 2019 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2019-02-06
March, 2011 FDA 483 MSD International GmbH (Puerto Rico Branch) LLC - Form 483, 2011-03-03
August, 2013 EIR Amgen Manufacturing Limited LLC - EIR, 2013-08-15
June, 2009 FDA 483 Biovail Laboratories International SRL - Form 483, 2009-06-30
August, 2018 EIR Janssen Ortho LLC - EIR, 2018-08-28
July, 2021 FDA 483 Response Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483R, 2021-08-02
February, 2022 FDA 483 Response Lilly del Caribe, Inc. - Form 483R, 2022-03-18
July, 2021 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2021-07-12
February, 2015 EIR Baxter Healthcare Corporation - EIR, 2015-02-06
December, 2010 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2010-12-10
April, 2022 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2022-04-01
March, 2014 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2014-03-29
July, 2009 FDA 483 Biovail Laboratories International SRL - Form 483, 2009-07-15
June, 2013 EIR Patheon Puerto Rico, Inc. - EIR, 2013-06-12
October, 2021 EIR Pisgah Laboratories Inc - EIR, 2021-10-21
May, 2015 FDA 483 Auro PR Inc. - Form 483, 2015-05-22
February, 2015 FDA 483 Baxter Healthcare Corporation - Form 483, 2015-02-06
October, 2018 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2018-10-24
September, 2012 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2012-09-18
May, 2018 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2018-05-31
February, 2022 FDA 483 Lilly del Caribe, Inc. - Form 483, 2022-02-25
September, 2011 FDA 483 Lopez Gonzalez Santana Corporation - Form 483, 2011-09-22
March, 2019 EIR AbbVie Biotechnology LTD - EIR, 2019-03-25
November, 2017 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2017-11-28
October, 2016 FDA 483 Baxter Healthcare Corporation - Form 483, 2016-10-03
February, 2013 FDA 483 Janssen Ortho LLC - Form 483, 2013-02-22
July, 2011 FDA 483 Teva Puerto Rico LLC - Form 483, 2011-09-11
July, 2021 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2021-07-12
March, 2018 EIR Cheng Fong Chemical Co., Ltd. Dayuan Factory - EIR, 2018-03-09
April, 2022 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2022-04-01
November, 2022 FDA 483 Teva Puerto Rico LLC - Form 483, 2022-11-23
July, 2013 FDA 483 Lilly del Caribe, Inc. - Form 483, 2013-07-23
June, 2013 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2013-07-30
February, 2022 EIR Lilly del Caribe, Inc. - EIR, 2022-04-13
March, 2019 FDA 483 AbbVie Biotechnology LTD - Form 483, 2019-03-25
October, 2015 FDA 483 Moehs Cantabra SL - Form 483, 2015-10-09
April, 2017 FDA 483 MARKSANS PHARMA LIMITED - Form 483, 2017-04-07
October, 2015 FDA 483 Interpharma Praha, a.s. - Form 483, 2015-10-16
March, 2011 FDA 483 AbbVie Biotechnology LTD - Form 483, 2011-04-29
December, 2018 EIR AbbVie Ltd - EIR, 2018-12-21
December, 2017 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2017-12-01
August, 2013 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2013-08-15
August, 2019 EIR Catalent Pharma Solutions, LLC - EIR, 2019-08-02
June, 2017 EIR Neolpharma, Inc. - EIR, 2017-06-07
July, 2023 FDA 483 King Bio Inc - Form 483, 2023-07-28
March, 2016 FDA 483 Janssen Pharmaceutica NV - Form 483, 2016-03-01
October, 2021 FDA 483 Pisgah Laboratories Inc - Form 483, 2021-10-21
June, 2012 EIR Auro PR Inc. - EIR, 2012-06-07
September, 2017 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2017-09-11
February, 2023 FDA 483 Ambiopharm, Inc. - Form 483, 2023-02-09
August, 2018 FDA 483 Janssen Ortho LLC - Form 483, 2018-08-28
October, 2015 EIR Biovet-AD - EIR, 2015-10-23
March, 2023 FDA 483 FUJIFILM Diosynth Biotechnologies UK Ltd - Form 483, 2023-03-17
December, 2011 FDA 483 Ex-Lax, Inc. - Form 483, 2011-12-15
August, 2018 FDA 483 Response Janssen Ortho LLC - Form 483R, 2018-09-19
April, 2020 FDA 483 Romark Global Pharma, LLC - Form 483, 2020-04-27
November, 2023 FDA 483 Empack Spraytech Inc. - Form 483, 2023-11-03
April, 2010 FDA 483 Puerto Rico Fertility and Reproductive Center PSC - Form 483, 2010-04-26
March, 2016 FDA 483 Lonza AG - Form 483, 2016-03-11
February, 2013 EIR Janssen Ortho LLC - EIR, 2013-02-22
April, 2020 FDA 483 Response Romark Global Pharma, LLC - Form 483R, 2020-05-14
March, 2018 FDA 483 Otsuka Pharmaceutical Co Ltd - Form 483, 2018-03-23
September, 2014 FDA 483 Combe Products, Inc. - Form 483, 2014-09-05
July, 2018 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2018-07-31
October, 2011 FDA 483 McNeil Healthcare LLC. - Form 483, 2011-10-26
December, 2019 FDA 483 Purdue Pharmaceuticals L.P. - Form 483, 2019-12-19
November, 2019 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2019-11-19
April, 2024 FDA 483 AbbVie Ltd - Form 483, 2024-04-18
June, 2019 FDA 483 Cross Brands Contract Filling - Form 483, 2019-06-10
December, 2009 FDA 483 Omega & Delta Co. Inc. - Form 483, 2009-12-07
April, 2013 EIR Teva Puerto Rico LLC - EIR, 2013-04-11
April, 2019 FDA 483 Mayo Clinic PET Radiochemistry Facility - Form 483, 2019-04-12
November, 2017 FDA 483 Response Actavis Laboratories FL, Inc. - Form 483R, 2017-12-22
February, 2018 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2018-02-21
May, 2015 EIR Auro PR Inc. - EIR, 2015-05-22
February, 2014 FDA 483 Bristol-Myers Squibb Manufacturing Company Unlimited Company - Form 483, 2014-02-20
May, 2014 FDA 483 Janssen Ortho LLC - Form 483, 2014-05-23
June, 2010 FDA 483 Bristol-Myers Squibb Manufacturing Company Unlimited Company - Form 483, 2010-06-25
August, 2009 FDA 483 UNIVERSAL MANUFACTURING CORP. - Form 483, 2009-08-27
April, 2013 FDA 483 Teva Puerto Rico LLC - Form 483, 2013-04-11
May, 2019 FDA 483 Sanit Technologies, LLC dba Durisan - Form 483, 2019-05-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more